PSIL vs. SURI ETF Comparison

Comparison of AdvisorShares Psychedelics ETF (PSIL) to Simplify Exchange Traded Funds Simplify Propel Opportunities ETF (SURI)

PSIL

AdvisorShares Psychedelics ETF

PSIL Description

AdvisorShares Trust - AdvisorShares Psychedelics ETF is an exchange traded fund launched and managed by AdvisorShares Investments, LLC. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across healthcare, pharmaceuticals, biotechnology and life sciences companies focused on plant-based psychedelic medicines as well as other companies with business activities in the psychedelics industry sectors. The fund uses derivatives such as swaps to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalization. The investment seeks long-term capital appreciation. AdvisorShares Trust - AdvisorShares Psychedelics ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$12.18

Average Daily Volume

32,540

Number of Holdings ^*

8

* may have additional holdings in another (foreign) market

SURI

Simplify Exchange Traded Funds Simplify Propel Opportunities ETF

SURI Description

The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$23.69

Average Daily Volume

5,487

Number of Holdings ^*

15

* may have additional holdings in another (foreign) market

Performance

Period	PSIL	SURI
30 Days	-3.95%	1.36%
60 Days	54.07%	2.75%
90 Days	34.56%	2.33%
12 Months	-9.88%	44.62%

1 Overlapping Holdings

	Symbol	Grade	Weight in PSIL	Weight in SURI	Overlap
	CMPS	F	5.4%	0.56%	0.56%

PSIL Overweight 7 Positions Relative to SURI

	Symbol	Grade	Weight
	MNMD	C	10.44%
	ATAI	C	7.66%
	GHRS	C	6.36%
	ALKS	B	5.34%
	RLMD	F	5.01%
	ITCI	C	4.94%
	SAGE	F	4.78%

PSIL Underweight 14 Positions Relative to SURI

	Symbol	Grade	Weight
	APLT	B	-24.2%
	PAGP	A	-21.27%
	PHAT	F	-8.7%
	AKRO	B	-6.84%
	MDGL	B	-5.87%
	RNA	D	-5.13%
	ARDX	F	-3.93%
	TSAT	D	-1.83%
	SNDX	F	-1.47%
	KYMR	D	-1.37%
	KURA	F	-1.3%
	ACHV	F	-0.99%
	ATHA	D	-0.62%
	VRCA	F	-0.27%

PSIL: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care Facilities

Keywords: Biopharmaceutical Entheogens Mental Health Psychoactive Drugs Depressive Disorder Drug Development Drugs Hyperactivity Disorder Major Depressive Disorder N Dimethyltryptamine Neurochemistry Neuroscience Psychiatric And Neurological Disorders Psychiatry Schizophrenia Treatment Resistant Depression Adjunctive Therapy Aging Associated Diseases Alcohol Alzheimer's Disease

SURI: Top Represented Industries & Keywords

Industries: Biotechnology Communication Equipment Medical Care Facilities Oil & Gas Midstream

Keywords: Biopharmaceutical Cancer Medicine Biotechnology Medication Metabolic Disease Solid Tumors Benzamides Breast Cancer Clinical Medicine Clinical Trial Gastrointestinal Life Sciences Pharmaceutical Products Thyroid Treatment Of Breast Cancer Acid Acute Leukemia Alcohol Antineoplastic Drugs